"AB-SA01 met the trial’s primary endpoints of safety and tolerability and all nine patients enrolled in the study experienced a reduction in the quantity of S. aureus infecting their sinuses, with some patients showing complete eradication of the bacterial infection."
Hope this is not hyperbole cause this is biggly if true going forward.
News 
Market Data 
Discover 
